Aimmune Therapeutics (AIMT) Files $250M Mixed Securities Shelf

September 6, 2016 12:32 PM EDT
Get Alerts AIMT Hot Sheet
Trade AIMT Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Aimmune Therapeutics (Nasdaq: AIMT) filed a registration with the U.S. SEC to sell up to $250 million of mixed securities.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment